1. Home
  2. TPCS vs LSTA Comparison

TPCS vs LSTA Comparison

Compare TPCS & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TechPrecision Corporation

TPCS

TechPrecision Corporation

N/A

Current Price

$5.26

Market Cap

45.1M

Sector

Industrials

ML Signal

N/A

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$1.58

Market Cap

28.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPCS
LSTA
Founded
1956
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Misc Health and Biotechnology Services
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.1M
28.9M
IPO Year
2008
2000

Fundamental Metrics

Financial Performance
Metric
TPCS
LSTA
Price
$5.26
$1.58
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $15.00
AVG Volume (30 Days)
23.6K
★ 310.7K
Earning Date
02-17-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 41.38
20.42
EPS
★ N/A
N/A
Revenue
$31,644,000.00
★ $35,283,868.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 56.90
52 Week Low
$2.88
$0.99
52 Week High
$6.31
$5.07

Technical Indicators

Market Signals
Indicator
TPCS
LSTA
Relative Strength Index (RSI) 44.28 45.82
Support Level $5.12 $1.33
Resistance Level $5.69 $2.06
Average True Range (ATR) 0.16 0.23
MACD -0.06 -0.01
Stochastic Oscillator 9.30 8.62

Price Performance

Historical Comparison
TPCS
LSTA

About TPCS TechPrecision Corporation

Techprecision Corp manufactures precision, large-scale fabricated and machined metal structural components and systems. The company provides end-to-end services, transforming raw materials into precision finished products through custom fabrication, precision machining, assembly, integration, inspection, non-destructive evaluation, and testing. It manufactures products in accordance with customers' drawings and specifications while complying with applicable national and international industry codes and standards. Its segments are: Ranor, which generates the majority of revenue, and Stadco, both focused on the manufacture and assembly of components mainly for defense and other precision industrial customers.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: